![]()
|
|
||||||||
| ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
Papers In Press, published online ahead of print September 12, 2002
Biology Division, National Cancer Center Research Institute, Tokyo 104-0045
Corresponding Author: jyokota{at}gan2.ncc.go.jp
To understand molecular pathways underlying 9p21 deletions, which lead to inactivation of the p16/CDKN2A, p14/ARF and/or p15/CDKN2B genes, in lymphoid leukemia, 30 breakpoints were cloned from 15 lymphoid leukemia cell lines. Seventeen (57 %) breakpoints were mapped at 5 breakpoint cluster sites, BCS-LL1 to LL5, each of <15-bp in size. Two breakpoint cluster sites were located within the ARF and CDKN2B loci, respectively, while the remaining three were located >100-kb distal to the CDKN2A, ARF and CDKN2B loci. The sequences of breakpoint junctions indicated that deletions in the 11 (73 %) cell lines were mediated by illegitimate V(D)J recombination targeted at the 5 BCS-LL and 6 other sites, which contain sequences similar to recombination signal sequences for V(D)J recombination. An extrachromosomal V(D)J recombination assay indicated that BCS-LL3, at which the largest number of breakpoints (i.e., 5 breakpoints) was clustered, has a V(D)J recombination potential 150-fold less than the consensus recombination signal sequence. Three other BCS-LLs tested also showed V(D)J recombination potential, although it was lower than that of BCS-LL3. These results indicated that illegitimate V(D)J recombination, that was targeted at several ectopic recombination signal sequences widely distributed in 9p21, caused a large fraction of 9p21 deletions in lymphoid leukemia.
J. Biol. Chem, 10.1074/jbc.M208353200
Submitted on August 15, 2002
Revised on September 12, 2002
Accepted on September 12, 2002
Prevalent involvement of illegitimate V(D)J recombination in chromosome 9p21 deletions in Lymphoid Leukemia
![]()
CiteULike
Complore
Connotea
Del.icio.us
Digg
Reddit
Technorati What's this?
This article has been cited by other articles:
![]() |
M. Zhang and P. C. Swanson V(D)J Recombinase Binding and Cleavage of Cryptic Recombination Signal Sequences Identified from Lymphoid Malignancies J. Biol. Chem., March 14, 2008; 283(11): 6717 - 6727. [Abstract] [Full Text] [PDF] |
||||
![]() |
H. Tsuji, H. Ishii-Ohba, T. Katsube, H. Ukai, S. Aizawa, M. Doi, K. Hioki, and T. Ogiu Involvement of Illegitimate V(D)J Recombination or Microhomology-Mediated Nonhomologous End-Joining in the Formation of Intragenic Deletions of the Notch1 Gene in Mouse Thymic Lymphomas Cancer Res., December 15, 2004; 64(24): 8882 - 8890. [Abstract] [Full Text] [PDF] |
||||
![]() |
S. C. Raghavan, S. Houston, B. G. Hegde, R. Langen, I. S. Haworth, and M. R. Lieber Stability and Strand Asymmetry in the Non-B DNA Structure at the bcl-2 Major Breakpoint Region J. Biol. Chem., October 29, 2004; 279(44): 46213 - 46225. [Abstract] [Full Text] [PDF] |
||||
![]() |
A. Li, M. Rue, J. Zhou, H. Wang, M. A. Goldwasser, D. Neuberg, V. Dalton, D. Zuckerman, C. Lyons, L. B. Silverman, et al. Utilization of Ig heavy chain variable, diversity, and joining gene segments in children with B-lineage acute lymphoblastic leukemia: implications for the mechanisms of VDJ recombination and for pathogenesis Blood, June 15, 2004; 103(12): 4602 - 4609. [Abstract] [Full Text] [PDF] |
||||
| HOME | HELP | FEEDBACK | SUBSCRIPTIONS | ARCHIVE | SEARCH |
| All ASBMB Journals | Molecular and Cellular Proteomics |
| Journal of Lipid Research | ASBMB Today |